Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lischka
    Junior Member
    • Oct 2009
    • 2

    #1

    Question about evaluation of 454 sequence

    Hi all,

    Lately our lab 454 sequenced a 5Mb human genome captured by nimblegen Seqcap array. And we got the sequence back 2 days ago from the sequence service. I just quickly looked at the report: the average length is a little more than 200bp and the short read % is about 50%. My question is that are these parameters within the normal range? How do you determine whether a sequence is good or bad for 454? Is there any document that I can refer to?

    Thanks!
  • vinay052003
    Member
    • Jan 2010
    • 59

    #2
    Hi,
    You've got 5MB of sequence data for human genome which reflects the low coverage over the entire genome. But as you did targeted sequening (Nimblegen SeqCap array), low amount of data does make sense.
    How short your reads are in "short read" category?

    Anyways.. if you want to check the quality of your sequences, you can plot the average quality scores against the %length of the sequencing read. Usually Q20 reflects 99% accuracy in 454 sequencing.
    One more way of quality check is to align these sequence to their targets and then plot the %identity with the number of sequences falling the in bins of %identity. Most of the sequences should show very high identity (>95%) if data is good and contains very little sequencing errors.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...